Micofenolato De Mofetil Farmoz

Mycophenolate Mofetil, the active ingredient in Micofenolato De Mofetil Farmoz, is an antimetabolite immunosuppressant presented as an oral tablet for systemic use. It is employed to prevent organ transplant rejection and to treat lupus nephritis by inhibiting lymphocyte proliferation in transplant recipients and patients with autoimmune kidney disease.

GNH USA supplies Micofenolato De Mofetil Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil is used in immunosuppressive therapy to reduce immune‑mediated organ damage. - Kidney transplant: helps prevent rejection of the transplanted kidney. - Heart transplant: reduces risk of graft rejection in heart recipients. - Liver transplant: supports long‑term graft survival by suppressing immune response. - Lupus nephritis: improves renal outcomes by decreasing autoimmune inflammation.

Mycophenolate Mofetil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, vomiting, diarrhea, abdominal pain. - Headache: mild to moderate intensity. - Infections: increased susceptibility to common bacterial or viral infections.

Serious or Rare Side Effects: - Severe opportunistic infection: e.g., Pneumocystis jirovecii pneumonia. - Progressive multifocal leukoencephalopathy (PML). - Bone marrow failure: aplastic anemia or severe pancytopenia.

When prescribing Mycophenolate Mofetil, several safety considerations are essential. - Pregnancy: contraindicated (Category X) due to risk of fetal toxicity. - Breastfeeding: not recommended because the drug is excreted in milk. - Renal impairment: dose may need adjustment; monitor renal function. - Hepatic impairment: use with caution; monitor liver enzymes. - Infection risk: screen for latent infections and consider prophylaxis. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Mycophenolate Mofetil interacts with several medicines that may alter its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce mycophenolate absorption. - Live vaccines: increased risk of severe infection. - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): markedly lower drug exposure.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone‑marrow suppression; monitor blood counts. - NSAIDs: may increase risk of renal impairment when combined.